SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-20-000857
Filing Date
2020-10-16
Accepted
2020-10-16 17:04:33
Documents
2
Period of Report
2020-09-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_6897.html 4  
1 PRIMARY DOCUMENT doc4_6897.xml 4 10113
2 EXHIBIT 24 exhibit24.htm EX-24 189
  Complete submission text file 0001638599-20-000857.txt   11669
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Clasby Jennifer G (Reporting) CIK: 0001728919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 201244575